Related references
Note: Only part of the references are listed.Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. An individual participant-level data meta-analysis
Denis Pouchain
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2021)
Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines
Mahdi Mahdavi et al.
BMC PUBLIC HEALTH (2020)
2018 Korean Society of Hypertension Guideline for the Management of Hypertension: A Comparison of American, European, and Korean Blood Pressure Guidelines
Sophia Larson et al.
EUROPEAN HEART JOURNAL (2020)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
Resistant hypertension in times of changing definitions and treatment recommendations
Milad Nazarzadeh et al.
HEART (2019)
Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review andmeta-analysis of randomized controlled trials
Abdul Salam et al.
JOURNAL OF HYPERTENSION (2019)
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)
Kazem Rahimi et al.
BMJ OPEN (2019)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura et al.
HYPERTENSION RESEARCH (2019)
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
Abdul Salam et al.
JOURNAL OF HYPERTENSION (2019)
2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
Hae-Young Lee et al.
CLINICAL HYPERTENSION (2019)
Hypertension Guidelines
Michel Burnier
EUROPEAN HEART JOURNAL (2018)
Blood pressure variability: clinical relevance and application
Gianfranco Parati et al.
JOURNAL OF CLINICAL HYPERTENSION (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels A Systematic Review and Meta-analysis
Mattias Brunstrom et al.
JAMA INTERNAL MEDICINE (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Randomized Controlled Trials of Blood Pressure Lowering in Hypertension A Critical Reappraisal
Alberto Zanchetti et al.
CIRCULATION RESEARCH (2015)
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
LANCET (2014)
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
Peter M. Rothwell et al.
LANCET (2010)
Mixed models showed no need for initial response monitoring after starting antihypertensive therapy
Katy J. L. Bell et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. R. Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses
LL Kjaergard et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
